Myeloproliferative Neoplasms News

Regardless of vaccination status, individuals with hematologic malignancies had increased odds of developing severe COVID-19 until oral antivirals became widely available in mid-2022, according to data published in JAMA Network Open.

The FDA placed a clinical hold on studies evaluating magrolimab for the treatment of acute myeloid leukemia and myelodysplastic syndromes, according to a statement released by the manufacturer.

Healio spoke with Akriti Jain, MD, about the existing unmet needs in MDS patient care.

  Healio spoke with Akriti Jain, MD, about aproaching the treatment of myelodysplastic syndrome based on where patients lie on the MDS spectrum.

Healio spoke with Akriti Jain, MD, about the pre-MDS conditions that have the potential to progress into MDS if left untreated.

Healio spoke with Akriti Jain, MD, about recent diagnostic and treatment developments in MDS.

Healio spoke with Akriti Jain, MD, about the future of MDS research, specifically combination treatments like azacitidine and venetoclax.

This year’s ASH Annual Meeting featured several high-impact abstracts.

In this video, Lindsay A.M. Rein, MD, discussed the Summit trial into treatment of systemic mastocytosis, data from which was presented at the ASH Annual Meeting and Exposition.

In this video, Lindsay A.M. Rein, MD, discussed the TRANSFORM-1 and MANIFEST-2 trials into combination therapies in myelofibrosis, both of which were presented at the ASH Annual Meeting and Exposition.